Hydrobromides
TARGETMOL CHEMICALS INC VORTIOXETINE HYDROBROMID 100MG
Also available in 10 mg 25 mg 50 mg 200 mg 500 mg 1000 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. Vortioxetine hydrobromide (Lu AA21004 hydrobromide) is a serotonin (5-HT) modulator and stimulator (SMS) inhibits 5-HT1A/1B/3A/7 receptor and SERT (IC50 15/33/3.7/19/1.6 nM). purity: 99%
TARGETMOL CHEMICALS INC PIFITHRIN-ALPHA HYDROBRO 25MG
Also available in 2 mg 5 mg 10 mg 50 mg 100 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. Pifithrin-(alpha) hydrobromide (Pifithrin-(alpha) hydrobromide) is a p53 inhibitor inhibiting p53-dependent transactivation of p53-responsive genes. purity: 98%
eMolecules 62595-74-8 | 3-Bromopiperidine-2,6-dione | AA Blocks LLC | MFCD11053059 | 192.012 | C5H6BrNO2 | 0.000 | BrC1CCC(=O)NC1=O | 25g | 560591993
3-Bromopiperidine-2,6-dione | AA Blocks LLC | 62595-74-8 | MFCD11053059 | 192.012 | C5H6BrNO2 | 0.000 | BrC1CCC(=O)NC1=O | 25g | 560591993
Medchemexpress LLC Remodelin hydrobromide | 1622921-15-6 | 99.6% | 363.28 | 1 ML
Remodelin hydrobromide is an orally active and selective inhibitor of acetyltransferase NAT10, which inhibits NAT10 activity and slows DNA replication.
- Suppresses the growth of prostate cancer cells.
- Inhibits the growth of prostate cancer and hepatocellular carcinoma in xenograft models.
- Enhances the healthspan in a Hutchinson-Gilford progeria syndrome (HGPS) mouse model.
TARGETMOL CHEMICALS INC TC-E 5003 200MG
Also available in 1 mL, 25 mg, 50 mg, 100 mg and bulk. Please contact Fisher for quotes. TC-E 5003 (NSC-30176) is a selective inhibitor of PRMT1 with IC50 of 1.5 uM. Purity 97.01%
eMolecules 768-66-1 | 2,2,6,6-Tetramethylpiperidine | Combi-Blocks | MFCD00005985 | 141.258 | C9H19N | 95.000 | CC1(C)CCCC(C)(C)N1 | 5g | 296391144
2,2,6,6-Tetramethylpiperidine | Combi-Blocks | 768-66-1 | MFCD00005985 | 141.258 | C9H19N | 95.000 | CC1(C)CCCC(C)(C)N1 | 5g | 296391144
Medchemexpress LLC Fatostatin hydrobromide (125B11 hydrobromide) | 298197-04-3 | 99.5% | C18H19BrN2S | 200 MG
Fatostatin hydrobromide (125B11 hydrobromide) is a specific inhibitor of SREBP activation that impairs the activation of SREBP-1 and SREBP-2. It binds to SCAP (SREBP cleavage-activating protein) and inhibits the ER-Golgi translocation of SREBPs.
- Impairs the activation of SREBP-1 and SREBP-2
- Binds to SCAP (SREBP cleavage-activating protein)
- Inhibits ER-Golgi translocation of SREBPs
- Decreases transcription of lipogenic genes in cells
- Possesses antitumor properties
- Lowers hyperglycemia in ob/ob mice
- For research use only
Apexbio Technology LLC TC-E 5003 17328-16-4 50mg
TC-E 5003 (CAS 17328-16-4) is a selective inhibitor of protein arginine methyltransferase 1 (PRMT1) exhibiting an IC50 of 1 5 M1 PRMT1 a member of the PRMT family mediates post-translational arginine methylation and is implicated in regulating diverse cellular processes Aberrant PRMT1 activity has been associated with a range of malignancies making it of interest for oncology research In cellular studies TC-E 5003 has been shown to inhibit proliferation and induce apoptosis in MCF7a breast cancer and LNCaP prostate cancer cell lines as well as attenuate androgen-induced gene expression in LNCaP cells This compound serves as a useful tool for investigating PRMT1 function and its role in cancer biology
eMolecules 62595-74-8 | 3-Bromopiperidine-2,6-dione | Ambeed | MFCD11053059 | 192.012 | C5H6BrNO2 | 97.000 | BrC1CCC(=O)NC1=O | 250mg | 506392068
3-Bromopiperidine-2,6-dione | Ambeed | 62595-74-8 | MFCD11053059 | 192.012 | C5H6BrNO2 | 97.000 | BrC1CCC(=O)NC1=O | 250mg | 506392068
Medchemexpress LLC Homatropine Bromide | 51-56-9 | 99.9% | 1 ML
Homatropine Bromide is an orally active muscarinic acetylcholine receptor antagonist. It functions as an anticholinergic agent and is intended for research applications only. This product is provided as a 10 mM solution in DMSO.
- Orally active muscarinic acetylcholine receptor antagonist
- Functions as an anticholinergic agent
- Provided as a 10 mM solution in DMSO
- Purity of 99.9%
- Suitable for research applications
Medchemexpress LLC Halofuginone hydrobromide | 64924-67-0 | 495.59 | 500 MG
Halofuginone hydrobromide is a Febrifugine derivative and a competitive prolyl-tRNA synthetase inhibitor with a Ki of 18.3 nM. It is a specific inhibitor of type-I collagen synthesis and attenuates osteoarthritis (OA) by inhibiting TGF-β activity. It also acts as a potent pulmonary vasodilator by activating Kv channels and blocking voltage-gated, receptor-operated, and store-operated Ca2+ channels.
- Competitive prolyl-tRNA synthetase inhibitor (Ki of 18.3 nM).
- Specific inhibitor of type-I collagen synthesis.
- Attenuates osteoarthritis (OA) by inhibition of TGF-β activity.
- Potent pulmonary vasodilator by activating Kv channels and blocking voltage-gated, receptor-operated, and store-operated Ca2+ channels.
- Has anti-malaria, anti-inflammatory, anti-cancer, and anti-fibrosis effects.